Changes of Diet, Physical Activity and Sleep Pattern and Their Effects on Glycemic and Weight Control in Hong Kong Chinese Obese Patients With Type 2 Diabetes After Bariatric Surgery Compared to Telephone Intensive Lifestyle Counselling

Diabetes Mellitus Type 2 in Obese Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02938026
• Other study ID #: Lifestyle-002
• Status: Completed
• Phase: N/A
• Start date: May 1, 2016
• Est. completion date: March 2018

Study information

• Verified date: July 2018
• Source: Chinese University of Hong Kong
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Nutrition therapy is recognized as one of the crucial components for the standard treatment of diabetes along with physical activity and drug therapy. Of note, dietary habits are culture specific and hence understanding the dietary intake, eating behavior and physical activity level of the local population is important to formulate effective nutrition and lifestyle strategies. Weight control is a major therapeutic challenge because many conventionally used anti-diabetic agents, such as sulphonylurea and insulin, can cause weight gain, thus setting up a vicious cycle with increasing insulin resistance due to increasing levels of free fatty acids from adipose tissues . Although intensive face-to-face lifestyle intervention program has showed that even modest weight loss in people with Type 2 diabetes (T2DM) who were overweight or obese was associated with improvements in glycemic control and associated conditions, it may not be feasible in public hospital setting in Hong Kong due to factors such as limited resources, scheduling, patient's employment and willingness for frequent travel to the clinic. Hence, alternative strategies such as a combination of face- to-face individual dietary and lifestyle consultation together with telephone intensive lifestyle reinforcement program will likely to be an useful strategy to engage those obese T2DM patients through frequent individual contacts. On the other hand, bariatric surgery has emerged as an impressive therapeutic option for poorly control obese T2DM patients.

Realizing there is a knowledge gap in understanding the lifestyle factors in the Hong Kong Chinese obese T2DM patients, we therefore propose to conduct a 1-year prospective clinical trial with two main objectives:

1. To study and compare the glycemic and weight improvement after bariatric surgery versus a telephone intensive lifestyle intervention program for 1 year in Hong Kong Chinese obese patients with type 2 diabetes.

2. To investigate the effect of lifestyle factors including dietary intake, eating behaviors and physical activity level on the glycemic and weight control of Hong Kong Chinese obese patients with type 2 diabetes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 141
• Est. completion date: March 2018
• Est. primary completion date: March 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

1. Age 18 - 65 years

2. Chinese ethnicity

3. BMI =27.5 kg/m2

4. Diagnosis of T2DM

5. No active cardiovascular diseases

6. ASA grade II or below (for the bariatric surgery group)

7. Able to read Chinese and give informed written consent

Exclusion Criteria:

1. Type 1 diabetes mellitus

2. End-stage renal failure requiring dialysis or chronic kidney disease (CKD) stage 4 or above

3. Malignancy diagnosed within 3 years

4. Major psychiatric illness

5. Pregnancy or lactation

6. Significant anaesthetic risk ASA grade III or above (for the bariatric surgery group)

7. Any medical illness or condition as judged by the investigators as ineligible to participate the study

Related Conditions & MeSH terms

• Diabetes Mellitus
• Diabetes Mellitus Type 2 in Obese
• Diabetes Mellitus, Type 2

Intervention

Procedure:
• Bariatric surgery

Behavioral:
• Telephone Intensive Lifestyle Counselling

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Chinese University of Hong Kong

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change of HbA1c		1 year
Primary	Change of weight		1 year